BiondVax Pharmaceuticals Ltd. Appoints Shai Ashkenazi to Scientific Advisory Board
September 07, 2016 at 02:00 pm
BiondVax Pharmaceuticals Ltd. announced the appointment of Professor Shai Ashkenazi to its Scientific Advisory Board (SAB). Ashkenazi is a clinical and regulatory vaccine expert, with significant contributions to flu and other infectious disease vaccine research and development. He has served on the clinical trial advisory boards for the development of a pediatric flu vaccine, vaccines for enteric infections, as well as other infectious diseases.